Video: Genetic Background in Syngeneic Models

Through this excerpt from Taconic Biosciences' Webinar, "Advanced Toolkit For Syngeneic Tumor Modeling in Mice," Dr. Philip Dubé considers the role of genetic background when identifying the proper syngeneic model as well as the importance of validating substrain and specific cell line.

Syngeneic models depend on the implanted tumor cell not being rejected by the immune system; it is crucial that cell lines are genetically matched to the host. The most critical aspect is that the tumor and the animal must be matched at the major and minor histocompatibility loci.

Tumor cell lines have been derived from a variety of inbred strains, see our "Featured Models" for the most common models.

What is the difference between C57BL/6J and C57BL/6N substrains?

These mice are genetically similar and well matched with respect to major and minor histocompatibility loci. Therefore, the transplantation of cells or tissues from any B6 substrain will be tolerated in any other B6 substrain.

However, there are genetic differences between these two substrains, which affect functions such as immunology and metabolism — and these may affect the subsequent growth of tumors and the response to therapeutic agents.

Featured Models

Black 6 (B6NTac)

C57BL/6, commonly called the B6 or Black 6, is among the most versatile inbred mouse strains and the preferred genetic background for several applications.
Black 6 (B6NTac)

BALB/c

A general purpose inbred strain for many different research disciplines.
BALB/c Inbred Mouse Model

C3H

C3H is used as a model for drug treatments of neurologic disorders.
C3H Inbred Mouse Model

DBA/2

DBA/2 is used in infectious disease studies, genetic studies and testing anticonvulsants.
DBA/2 Inbred Mouse Model

Related Resources

On-Demand Webinar

While the specialized immune systems of xenograft tumor models allow us to investigate specific human cancers, further progress in immuno-oncolgy depends on more representative modeling of the tumor microenvironment.

WHITE PAPER

The advent of immuno-oncology has necessitated changes in the types of animal models used in oncology drug discovery. Syngeneic models—inbred mice bearing an engrafted tumor derived from a genetically identical mouse strain—are invaluable preclinical research tools that enable tumor studies in the context of a complete and functional immune system.


Connect with an expert